Drug Profile
Levothyroxine sodium - IBSA
Alternative Names: L-thyronine-sodium - IBSA; L-thyroxine-sodium - IBSA; Levothyroxine - IBSA; Levothyroxine sodium liquid gel capsules - IBSA; Levothyroxine sodium oral solution; Levothyroxine-sodium-I-125 - IBSA; LT4 - IBSA; Monosodium-L-thyroxine-hydrate - IBSA; T4 - IBSA; Thyroxine-I-125 - IBSA; Thyroxine-sodium - IBSA; Tirosint; Tirosint - IBSA; Tirosint-SOLLatest Information Update: 06 Dec 2023
Price :
$50
*
At a glance
- Originator IBSA
- Developer Akrimax Pharmaceuticals; IBSA
- Class Aromatic amino acids; Small molecules; Thyroid hormones
- Mechanism of Action Hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypothyroidism